Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept and Mifepristone for Gulf War Illness
NCT04255498Phase 1Unknown
- Sponsor
- South Florida Veterans Affairs Foundation for Research and Education
- Start
- Oct 2017
- Primary completion
- Aug 2019
- Modality
- Orthosteric Ligands, Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of etanercept and mifepristone in Gulf War syndrome (GWS), sponsored by South Florida Veterans Affairs Foundation for Research and Education. Primary endpoint: Biomarker response to therapy using Cytokine panel at 16 weeks. Status: unknown.
02
Drugs
etanerceptmifepristone
03
Conditions
Gulf War syndrome (GWS)
Beyond the preview
Go deeper on NCT04255498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04255498.